JP2013537190A - 非経口投与のための抗菌作用を有する医薬組成物及びその製造方法 - Google Patents
非経口投与のための抗菌作用を有する医薬組成物及びその製造方法 Download PDFInfo
- Publication number
- JP2013537190A JP2013537190A JP2013528146A JP2013528146A JP2013537190A JP 2013537190 A JP2013537190 A JP 2013537190A JP 2013528146 A JP2013528146 A JP 2013528146A JP 2013528146 A JP2013528146 A JP 2013528146A JP 2013537190 A JP2013537190 A JP 2013537190A
- Authority
- JP
- Japan
- Prior art keywords
- silicon dioxide
- mass ratio
- pharmaceutical composition
- bhsio
- finely dispersed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EA201001449 | 2010-09-13 | ||
EA201001449A EA021874B1 (ru) | 2010-09-13 | 2010-09-13 | Фармацевтическая композиция антимикробного действия для парентерального введения и способ ее получения |
PCT/RU2011/000320 WO2012036585A1 (ru) | 2010-09-13 | 2011-05-11 | Фармацевтическая композиция антимикробного действия для парентерального введения и способ её получения |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2013537190A true JP2013537190A (ja) | 2013-09-30 |
Family
ID=45908207
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2013528146A Withdrawn JP2013537190A (ja) | 2010-09-13 | 2011-05-11 | 非経口投与のための抗菌作用を有する医薬組成物及びその製造方法 |
Country Status (9)
Country | Link |
---|---|
JP (1) | JP2013537190A (ru) |
CN (1) | CN103096896A (ru) |
AU (1) | AU2011302724C1 (ru) |
BR (1) | BR112012023964A2 (ru) |
CA (1) | CA2785228A1 (ru) |
EA (1) | EA021874B1 (ru) |
MX (1) | MX2012010535A (ru) |
NZ (1) | NZ598831A (ru) |
WO (1) | WO2012036585A1 (ru) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0890359B1 (en) * | 1996-02-29 | 2002-05-02 | Fujisawa Pharmaceutical Co., Ltd. | Tablets containing beta-lactam antibiotic and process for producing the same |
BRPI0716658A2 (pt) * | 2006-08-11 | 2015-02-10 | Panacea Biotec Ltd | Partículas para distribuição de ingredientes ativos, processo de fabricação e suas composições |
RU2377985C2 (ru) | 2006-12-25 | 2010-01-10 | Сергей Михайлович Юдин | Средство для лечения инфекционных болезней, вызванных множественно-устойчивыми бактериями |
-
2010
- 2010-09-13 EA EA201001449A patent/EA021874B1/ru not_active IP Right Cessation
-
2011
- 2011-05-11 CN CN2011800044095A patent/CN103096896A/zh active Pending
- 2011-05-11 BR BR112012023964A patent/BR112012023964A2/pt not_active IP Right Cessation
- 2011-05-11 MX MX2012010535A patent/MX2012010535A/es not_active Application Discontinuation
- 2011-05-11 JP JP2013528146A patent/JP2013537190A/ja not_active Withdrawn
- 2011-05-11 WO PCT/RU2011/000320 patent/WO2012036585A1/ru active Application Filing
- 2011-05-11 NZ NZ598831A patent/NZ598831A/xx not_active IP Right Cessation
- 2011-05-11 CA CA2785228A patent/CA2785228A1/en not_active Abandoned
- 2011-05-11 AU AU2011302724A patent/AU2011302724C1/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
NZ598831A (en) | 2013-11-29 |
CN103096896A (zh) | 2013-05-08 |
EA201001449A1 (ru) | 2012-02-28 |
WO2012036585A8 (ru) | 2012-10-04 |
MX2012010535A (es) | 2012-11-16 |
EA021874B1 (ru) | 2015-09-30 |
CA2785228A1 (en) | 2012-03-22 |
BR112012023964A2 (pt) | 2016-08-02 |
AU2011302724A1 (en) | 2012-05-03 |
AU2011302724C1 (en) | 2012-11-29 |
WO2012036585A1 (ru) | 2012-03-22 |
AU2011302724B2 (en) | 2012-06-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Duan et al. | Metal–carbenicillin framework-based nanoantibiotics with enhanced penetration and highly efficient inhibition of MRSA | |
AU2015244275B2 (en) | Liposomal ciprofloxacin formulations with activity against non-tuberculous mycobacteria | |
CA2842779A1 (en) | Pharmaceutical compositions comprising beta-lactam antibiotic, sulbactam and beta-lactamase inhibitor | |
CA2889793C (en) | Antibacterial compositions | |
EP2596783B1 (en) | Pharmaceutical composition for the preparation of infusion solutions of antimicrobial preparations, its production process | |
EP3412289A1 (en) | Antibacterial compositions | |
Rana et al. | Nanoantibiotic formulations to combat antibiotic resistance-old wine in a new bottle | |
JP2013537190A (ja) | 非経口投与のための抗菌作用を有する医薬組成物及びその製造方法 | |
EP2950804B1 (en) | Antibiotic preparation and use thereof | |
WO2012154076A1 (ru) | Фармацевтическая композиция антибактериального действия для парентерального применения, способ её получения | |
EP2620152A1 (en) | Pharmaceutical composition with antimicrobial activity for parenteral administration and process for preparing same | |
JP2013537226A (ja) | 非経口投与のための抗菌性および抗炎症性作用を有する医薬組成物、並びにその製造方法 | |
CN1167618A (zh) | 抗β-内酰胺酶抗菌素复合物 | |
WO2012154077A1 (ru) | Фармацевтическая композиция для лечения туберкулёза и других инфекций, способ её получения | |
Kraskouski et al. | Preparation and Properties of Complexes Based on Chitosan-Ag Nanocomposite and Cephalosporin Antibiotics | |
Basu et al. | Βeta-Lactams as Clinically Active Medicines | |
Ahmad et al. | Antibiotic Resistance Breakers and Nano-Antibiotics in Mediating Antimicrobial Resistance | |
WO2012154078A1 (ru) | Фармацевтическая композиция антимикробного действия для парентерального применения, способ её получения | |
NZ601748B (en) | Pharmaceutical composition for the preparation of infusion solutions of antimicrobial preparations, its' production process |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A300 | Withdrawal of application because of no request for examination |
Free format text: JAPANESE INTERMEDIATE CODE: A300 Effective date: 20140805 |